Proactive Investors - Run By Investors For Investors

ImmunoPrecise Antibodies on an aggressive sales and business development drive

ImmunoPrecise Antibodies Ltd's (CVE:IPA) president and chief executive Jennifer Bath caught up with Proactive Investors at the Spring Investor Summit 2019 in New York City.

Operating from their laboratory facilities at the Vancouver Island Technology Park in Victoria, British Columbia …  ImmunoPrecise is an 'end-to-end' provider for accelerated antibody research and discovery.

 
View full IPA profile View Profile

ImmunoPrecise Antibodies Ltd Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use